Vanguard Portfolio Management
IRMD icon

Vanguard Portfolio Management’s iRadimed IRMD Stock Holding History

Vanguard Portfolio Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
125,357
+2,932
+2% +$267K ﹤0.01% 2142
2026
Q1 		$11.8M Buy
+122,425
New +$12.2M ﹤0.01% 2066

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management's IRMD Position: Q2 2026 in Review

Vanguard Portfolio Management increased its iRadimed (IRMD) stake by 2.4% in Q2 2026, buying an estimated $267K and bringing the position to 125,357 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Vanguard Portfolio Management first reported a position in IRMD in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Vanguard Portfolio Management held 125,357 shares of iRadimed worth $12M as of Q2 2026.
  • Vanguard Portfolio Management bought 2,932 iRadimed shares in Q2 2026, an estimated $267K.
  • iRadimed made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2142 holding.
  • Vanguard Portfolio Management first reported a position in iRadimed in Q1 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.